Comments
Roche says arthritis drug beats top-selling rival in trial
06.06.2012. | ZURICH (Reuters) - Roche said on Wednesday that a trial had shown its rheumatoid arthritis drug RoActemra was more effective in reducing swelling and tenderness in joints than Abbott Laboratories' top-selling Humira when given as a single treatment....
